Xometry, Inc. (NASDAQ:XMTR – Get Free Report) insider Subir Dutt sold 3,929 shares of the stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $65.55, for a total transaction of $257,545.95. Following the transaction, the insider directly owned 67,419 shares of the company’s stock, valued at $4,419,315.45. This trade represents a 5.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Subir Dutt also recently made the following trade(s):
- On Wednesday, November 19th, Subir Dutt sold 2,075 shares of Xometry stock. The stock was sold at an average price of $60.00, for a total value of $124,500.00.
Xometry Price Performance
NASDAQ:XMTR opened at $68.25 on Thursday. The business’s 50-day moving average is $60.17 and its 200 day moving average is $49.77. Xometry, Inc. has a 12 month low of $18.59 and a 12 month high of $69.26. The company has a market capitalization of $3.50 billion, a P/E ratio of -54.60 and a beta of 0.86. The company has a current ratio of 3.62, a quick ratio of 3.58 and a debt-to-equity ratio of 1.20.
Xometry News Summary
Here are the key news stories impacting Xometry this week:
- Positive Sentiment: Analyst/market recognition: Xometry’s composite rating climbed to 96 in a recent write‑up, a headline that can attract momentum investors and institutional interest. Read More.
- Neutral Sentiment: Third‑party coverage: A comparative review of Xometry and a peer was published; useful for awareness but unlikely to move the stock materially unless it contains new forecasts or catalyst details. Read More.
- Negative Sentiment: Clustered insider selling: Multiple senior executives and a director disclosed coordinated sales in early January (CEO Randolph Altschuler, CFO James Miln, President Sanjeev Sahni, CTO V. Raghavan, insider Subir Dutt and Director Emily Rollins). Combined disclosures represent several hundred thousand to over a million dollars of proceeds and reduced holdings by ~4–8% for some insiders — a signal investors often interpret cautiously even if sales are for diversification or option exercises. Representative SEC filings: CEO Read More., CFO Read More..
Institutional Trading of Xometry
Institutional investors have recently added to or reduced their stakes in the company. Corebridge Financial Inc. boosted its position in shares of Xometry by 1.6% during the first quarter. Corebridge Financial Inc. now owns 21,481 shares of the company’s stock valued at $535,000 after buying an additional 348 shares during the period. Royal Bank of Canada raised its holdings in shares of Xometry by 5.0% in the first quarter. Royal Bank of Canada now owns 60,669 shares of the company’s stock worth $1,511,000 after buying an additional 2,899 shares during the period. AQR Capital Management LLC bought a new stake in shares of Xometry during the 1st quarter worth approximately $692,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Xometry by 7.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,054 shares of the company’s stock valued at $649,000 after acquiring an additional 1,877 shares during the period. Finally, Goldman Sachs Group Inc. grew its position in Xometry by 26.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 452,682 shares of the company’s stock valued at $11,281,000 after acquiring an additional 95,154 shares during the last quarter. Institutional investors own 97.31% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have commented on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Xometry in a research note on Wednesday, October 8th. Citigroup reaffirmed an “outperform” rating on shares of Xometry in a report on Wednesday, November 5th. The Goldman Sachs Group boosted their price objective on Xometry from $49.00 to $56.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. JPMorgan Chase & Co. raised their price objective on Xometry from $55.00 to $70.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Finally, Citizens Jmp lifted their target price on Xometry from $65.00 to $75.00 and gave the stock a “market outperform” rating in a report on Wednesday, November 5th. Five equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $57.89.
Read Our Latest Research Report on Xometry
Xometry Company Profile
Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.
Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.
Recommended Stories
- Five stocks we like better than Xometry
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.
